VEGFA and melanoma: Tóth-Jakatics et al. [86,88] demonstrated that in cutaneous malignant melanomas intradermal mast cells are immunoreactive to VEGF and demonstrated a prognostic significance of mast cell density and microvascular density in melanoma patients, showing a shorter survival rate in patients with highly values of these parameters.